Package 60505-0042-6

{"route": ["ORAL"], "spl_id": "ca931d58-7d38-8516-2997-f61253819cb9", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "unii": ["X4HES1O11F"], "rxcui": ["197310"], "spl_set_id": ["41bea43a-f58c-2c6f-4d31-406ceb456077"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Apotex Corp."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (60505-0042-6)", "package_ndc": "60505-0042-6", "marketing_end_date": "20270430", "marketing_start_date": "20060320"}], "brand_name": "ACYCLOVIR", "product_id": "60505-0042_ca931d58-7d38-8516-2997-f61253819cb9", "dosage_form": "CAPSULE", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "60505-0042", "generic_name": "ACYCLOVIR", "labeler_name": "Apotex Corp.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ACYCLOVIR", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "200 mg/1"}], "application_number": "ANDA075677", "marketing_category": "ANDA", "marketing_end_date": "20270430", "marketing_start_date": "20060320"}